Standardizing the Benefit-Risk Assessment of New Medicines Lawrence LibertiJames Neil McAuslaneStuart Walker Current Opinion 23 August 2012 Pages: 139 - 146
The Role of Health-Related Quality of Life Data in the Drug Approval Processes in the US and Europe Patrick MarquisMartine CaronCatherine Acquadro Original Research Article 23 August 2012 Pages: 147 - 160
23rd Annual EuroMeeting of the Drug Information Association Mary Ellen Kitler Meeting Report 23 August 2012 Pages: 161 - 166
Drug and Device Shortages Hiroto NarimatsuTomoko MatsumuraMasahiro Kami Correspondence 23 August 2012 Pages: 167 - 167